1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sarcomas, Epitheliod: new trials by email Literature Review of Sarcomas, Epitheliod trials Research Report on Sarcomas, Epitheliod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
Dermatofibrosarcoma (1) · Fibrosarcoma (1) · Histiocytoma (1) · Melanoma (1) · Neoplasms (1) · Neuroblastoma (1) · Osteosarcoma (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1)
Myosarcoma (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1) · Neuroectodermal Tumors, Primitive (1) · Neuroectodermal Tumors, Primitive, Peripheral (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1)
Celgene (1)
Canada (1) · France (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)